Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions books & textbook
Regulatory Processes for Rare Disease Drugs in the United States and European Union: Flexibilities and Collaborative Opportunities
Health and Medicine Division Carolyn K. Shore Tequam L. Worku Carson W. Smith Jeffrey P. Kahn Board on Health Sciences Policy Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions
National Academies Press /2025-06-12 Paperback / 319 Pages
isbn-10: 0309726557 / isbn-13: 9780309726559
